Analysis of Nanjing Pharmaceutical Co. Sees Top Management Shakeup: Directors Nominated by Former Foreign Shareholder Ousted, Executives from Guangzhou Pharmaceutical Group Nominated - aVenture Research
BigGo Finance
Nanjing Pharmaceutical Co. Sees Top Management Shakeup: Directors Nominated by Former Foreign Shareholder Ousted, Executives from Guangzhou Pharmaceutical Group Nominated
Following the complete exit of its former second-largest shareholder, Alliance Healthcare, the board and management of Nanjing Pharmaceutical Co. (600713.SS) are undergoing significant changes. At a recent board meeting, the company proposed removing two directors nominated by the foreign shareholder and dismissing one of them from his concurrent role as vice president. Notably, Luo Xunjie, one of the individuals proposed for removal, abstained from voting on the relevant proposals. Meanwhile, c